Camille Madelon is Director of Strategy and Business Development at Envirotainer. She is a also a member of the Envirotainer Management Team. Her role spans corporate strategy as well as product, service and overall offering development. Before joining Envirotainer in 2013, Camille was Senior Healthcare Principal at the Boston Consulting Group (BCG), a leading consultancy, where she worked for large Pharma and Medical Technology companies. She studied economics and management at ESSEC business school and as well as conducted a PhD at HEC Paris (France).

Jen  is Vice President, Global Planning with global responsibility for supply and demand planning, S&OP, and inventory optimization for Allergan.  Allergan is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand, OTC and biosimilar products with over $20B in revenue.  Jen has been involved in integration of Allergan, Forest, Warner Chicott, and Actavis in her three years with the company.  Prior to that, , Jen was with Johnson & Johnson for 10 years in Consumer Products and Pharmaceutical sectors in both NJ and the Bay Area.  She had a variety of leadership roles including commercialization of an innovative combination drug device, new product project management, and supply chain planning.

Jen has a BSE in Operations Research from Princeton University and an MBA from Harvard University. 

Jim started his career with Ford Motor Company as a Design Engineer (1988 – 1990).  He then moved to Coopers & Lybrand as a Senior Manufacturing Consultant (1990 – 1993). 

In 1993, Jim moved to Wyeth Pharmaceuticals as part of the manufacturing & operations analysis team.  From 1996 to 2004, he held several positons within the manufacturing, materials management, customer order management, physical distribution, and information technology functions.  In 2004, Jim relocated to the United Kingdom and was appointed V.P. EMEA Manufacturing & Supply Chain.  He was responsible for the regional manufacturing assets (4 plants) and the third party manufacturing network (55 thirds parties) and a member of the European Commercial Leadership Team.  In 2008, Jim relocated back to the United States and was appointed V.P. Global Logistics, responsible for all aspects of product movement, storage, and order management activities on a global basis.

In 2009, Jim came to Pfizer as V.P. Supply Network Services.  In this role he was responsible for designing and deploying supply chain “platform services” within Pfizer Global Supply.  This included logistics network design, transportation management, supply chain process and information management, customs compliance, logistics security, and EH&S regulatory compliance.   In 2014, Jim was appointed to his current role, V.P. Network Supply Operations.  Jim is responsible for the worldwide demand and supply planning, inventory management, performance measurement, supply chain processes, and global customs compliance for the Consumer Health, Vaccine, Oncology, Innovative, and Established business units.

Jim holds a B.S. Industrial Engineering, and a M.S. Mechanical Engineering, from the University of Rhode Island.  In addition, Jim holds an M.S. Technology Management, from the University of Pennsylvania, College of Engineering and the Wharton Business School.

Joe Short has a successful career in the healthcare / pharmaceutical sector.  Over the last twenty years he has worked with Cardinal Health and AmerisourceBergen, both Fortune 30 organizations. With Cardinal health Joe was responsible for Divisions in Chicago, Detroit, and San Francisco. During his career with AmerisourceBergen he has been responsible for multiple Divisions in Minneapolis, Kansas City, and Chicago.  In 2007 he became the Regional Vice President for the South Region with responsibility for ten Southern United States and Puerto Rico. In 2012 he went on to become the Regional Vice President for the Eastern United States, the largest of the four regions with six Divisions.  Joe then became President of AmerisourceBergen Canada with nine Divisions.  Joe is currently the Senior Vice President of Operations for AmerisourceBergen Drug Corporation.  Joe has a Bachelor’s degree from Northwestern University, majoring in Economics, a Master’s Degree from the University of London in International Management, and is currently engaged in Doctoral studies at Georgetown University.

Mr. Julio Feliciano is Associate Vice President, in the Supply Chain Management organization for the Manufacturing Division of Merck & Co., Inc. Julio has currently responsibility for development and implementation of Global Supply Network Rationalization plans.

Julio holds a Masters Degree in Pharmaceutical Sciences from Lisbon University, specializing in Industrial Pharmacy. He is also an APICS Certified Supply Chain Professional.  

Julio joined Merck in 1990 and has held various positions of increased responsibility: 
• Eight years in Quality Management in three different European sites, and acting as Qualified Person.
• Eight years as Plant Manager in Spain, transforming the local site into a global supplier of key medicines.
• Six years of Global Supply Chain Management responsibilities, implementing lean standard work in Regional Planning Hubs, upskilling capabilities and leading Global Supply Planning Integration post merger with Schering Plough.

Todd Applebaum leads the supply chain, manufacturing and quality operations at Ovascience, building the company’s operations infrastructure as they develop and commercialize new fertility treatments.  In this role, Mr. Applebaum brings more than 25 years of experience in manufacturing, supply chain management, strategy and information technology consulting. He has led strategic and operational initiatives at both large and emerging life sciences and healthcare clients, and is recognized for his expertise in manufacturing, operations, commercialization planning and inter-enterprise supply chain collaboration.

Prior to joining OvaScience, Mr. Applebaum served as VP of Research in Gartner's Supply Chain Research group, focused on healthcare and life sciences. In this role, Mr. Applebaum advised Gartner's life science and healthcare clients (pharma, biotech and device manufacturers, wholesalers, pharmacies, payers, and providers) on business and technology strategies and best practices.

As a founder and vice president at Maxiom Consulting Group, a provider of supply chain management, operations and commercialization services to life sciences companies, Mr. Applebaum delivered a range of services to life sciences companies across technical operations, product development and product supply. Before focusing exclusively on life sciences, Mr. Applebaum served as a partner at Benchmarking Partners, where he played a key role in the development and delivery of the Value Chain Strategies and Partnership Strategies service lines across the consumer products, electronics and industrial industries. While at Benchmarking Partners, he was also part of a team of practitioners that taught a Massachusetts Institute of Technology course for executives and graduate students titled, "Developing the CEO Team's Value Chain Network Strategy." Mr. Applebaum's work with manufacturers began in the automotive industry at General Motors and TRW, in operating roles including production management, materials management, planning and scheduling, product development, and system integration. As a manager in the Manufacturing Practice of Deloitte Consulting, Mr. Applebaum went on to work with a spectrum of multinational manufacturers on business process re-engineering, technology assessment and selection, and best-practice implementation efforts.

Paul Nelson joined Auxilium Pharmaceuticals in 2014 as Executive Director, Supply Chain Operations.  Auxilium has subsequently been acquired by Endo Pharmaceuticals. Paul has over twenty five years of pharmaceutical industry experience in Supply Chain, Production, and Engineering.  In his current role, Paul is responsible for the coordination of all activities related to maintaining the supply chain for all clinical and commercial products, from sourcing through delivery.  Paul directs production planning, scheduling, inventory management, technical material procurement, CMO contract and business relationship management for all our products.  Prior to joining Auxilium, Paul worked for Shire Pharmaceuticals, where he spent the last ten years and was most recently responsible for Supply Chain Operational Excellence and Transformational Change.  Prior to Shire, Paul held senior level roles at UCB Bioproducts, Inc., UCB Pharma, and Day Engineering.  Paul possesses a Bachelor of Science degree in Applied Mathematics from Kentucky State University, a Bachelor of Science degree in Chemical Engineering from the University of Kentucky, and an M.B.A. in International Business from the University of South Carolina.

Mike started his career with Novartis in 1984 as a process engineer at the then Ciba-Geigy facility in Summit NJ.  Mike steadily progressed to senior Process engineer in the Chemical Development group,  overseeing the manufacture of  Drug Substance used in clinical testing.
 
Mike then went on to manage the Commercial Drug Substance operations at the Summit site.  His next assignment was to direct all Commercial Manufacturing operations at the Summit site before the site was closed and operations moved to alternate Novartis facilities.

Mike then moved to the Suffern, NY site as head of Quality Management and Training where he laid the groundwork for the very successful LEAN manufacturing implementation at the plant.  In 2001, Mike moved to the Supply Chain Management organization at the East Hanover, NJ site.
 
Mike managed the  Project management group in Supply Chain for all new Product launches, Production transfers, and Life cycle management changes for the Novartis US pharmaceutical business.

Mike’s latest role is Global Pharma Supply Chain lead for Cell Therapies. Mike has a BE degree in Chemical Engineering from Stevens Institute of Technology, a Master’s certificate in Project Management from The George Washington University,  holds the APIC’s CPIM certification and is a licensed professional engineer in the state of NJ.

Carl Accettura is the Vice President & General Manager for PharmoRx Therapeutics, Inc., engaged in early stage development of novel therapy for the central nervous system, including Treatment Resistant Depression and Parkinson’s Disease.
Carl has 30 years of BioPharma industry experience with both Big Pharma - Pfizer, Roche, BMS – and Emergent Pharma companies - Anesta, Cephalon, Kyowa Hakko Kirin, Dainippon Sumitomo Pharma, Sunovion, and Braeburn Pharmaceuticals.
Carl has held executive level (VP) positions in the areas of supply chain, new product development and operations. He has overseen the development of end-to-end supply chain strategies, operations, and product launches across the US, Europe and Asia.
Carl successfully launched major branded drugs (Procardia XL, Diflucan, Norvasc, Zithromax, Zoloft, Cardura, Actiq and Latuda) globally. He did this by ensuring advanced commercial readiness through effective global and regional regulatory filings and approvals. He founded a consulting firm, Global Pharma Consulting, which was established to support small and medium-sized companies commercialize Rx products.
Carl’s most recent role was Vice President, Supply Chain at Braeburn Pharmaceuticals, where he developed the virtual supply chain for commercial launch readiness of a novel opioid implant product. He championed a novel trace and trace solution with partner, Covectra, for Probuphine’s strategic positioning as the “safest in the market”. He now supports Track & Trace solutions in the Life Sciences for Covectra.
Carl’s subject matter expertise in pharmaceutical new product launch and supply chain management makes him a sought after speaker.      He speaks each semester at the Cornell University Enterprise Engineering Seminar.
Carl earned a B.S. with distinction from Cornell University in Mechanical Engineering. He also holds a M.S. from University of Illinois and a M.B.A from the Stern School at New York University.

Greg leads global supply chain for pharmaceutical products at Lilly, where his main goal is providing the organizational leadership to ensure robust and efficient supply chains for Lilly’s products, including new product launches.

Mr. Luthman has over 25 years of director-level experience at Fortune 100 companies, including Ford Motor Company and Bristol Myers Squibb in both manufacturing and pharmaceutical distribution. His range of expertise included Warehouse Operations, Customer Service, Strategic Planning and Project Management in both domestic and international supply chain operations. Mr. Luthman received a Bachelor of Science degree in Accounting from Monmouth University.

Ed Ram joined Sagent Pharmaceuticals in February 2013 as Senior Director, Supply Chain.
Ed has over 20 years of supply chain and strategic sourcing experience working with Baxter Healthcare, Allegiance Healthcare, and Cardinal Health.  He has a track record of change and innovation employed to create improved supply chains between business partners.  These accomplishments include utilization of score carding, vendor managed inventory (VMI), electronic data interface (EDI), freight lane and network optimization, and business modeling.  His supply chain work at Baxter is featured in the book – Supply Chain Optimization.
Previous to Ed’s association with the healthcare industry, he was with Accenture in their distribution products practice.  His client engagements included Sears and North American Philips.
Ed has also completed 22 years of service in the U.S. Navy and U.S. Naval Reserve Supply Corps achieving the rank of Commander.  He has received awards for his logistics and procurement work including the Navy Commendation Medal and the Joint Services Achievement Medal.
He has a BS in Economics from The Wharton School, University of Pennsylvania and an MBA in Finance and Marketing from Booth GSB, University of Chicago.

Michele has over 20 years of experience in the pharmaceutical industry during which 15 years have been focused on supply chain management. Currently she is at Sandoz where she is the Director, Supplier Relationship Management. She has responsibilities for both program management and supplier relationships. Prior to Sandoz, Michele was an industry consultant utilizing her expertise in supply chain and project management. During her consulting days, she also became a leader in the management of temperature sensitive products. Michele started her career with Merck. During her tenure at Merck, she was Executive Director, New Products Management, where she led a group of experienced professionals in the management and execution of new product supply chains supporting launches of products world-wide.

Head of Resource Planning and Strategy at GSK Vaccines (formerly Novartis Vaccines), Amir leads a team of project managers, analysts and Advanced Planning System (APS) managers. Related to the conference topics, Amir sponsored in the recent year a project that focused on implementing a new S&OP Advanced Planning System, a second project focusing on S&OP process improvement and a third project focused on building the company's Portfolio Prioritization Guideline and related decision support tools. Amir is APICS CSCP certified, holds an MBA from the Wharton School of Pennsylvania University and a Master’s degree in Biotechnology Engineering from Ben-Gurion University, Israel.

Marcelo has 20 years experience in the health care and consumer/ high tech industry with Bristol-Myers Squibb and other Fortune 500 companies. He has held management positions in the areas of logistics, operations management, supply chain planning, customer service and international trade both in South and North America. His current role at BMS is Regional Director, Global Logistics Services responsible for distribution strategy, logistics compliance, 3PL management, best practices implementation and customer service.

Jeff has 30 plus years of experience in the Pharmaceutical Industry, first as an Industrial Engineer for 15 years and then in various Supply Chain positions since. He is a licensed Professional Engineer and APICS certified; CPIM and CSCP, holds a bachelor degree in Industrial Engineering and a master’s degree in Management. Jeff has also been a LogiPharma Advisory Board member for the last 8 years and an active participant before that.

Setting the right internal culture to adapt to the Supply Chain of the future through continuous improvement & innovation
-    It is critical that everyone understand what the Supply Chain mission is currently and where it needs to be for the future.
-    A buy in to the concept that to meet the future needs of the business Supply Chain needs to be adaptive and able to react to change
-    By its nature, continuous improvement means that you are continually reviewing the current situation and looking ahead at ways to improve, becoming better prepared to face the challenges that lay ahead.
-    Innovation is the competitive edge. If you’re doing just what others have done then you have no competitive advantage over them.
Session statement: If your organization doesn’t understand what Supply Chain’s mission is and where you’re going you don’t have a chance of getting there. Continuous Improvement and Innovation are critical by reviewing your current operations and looking at innovative ways to improve it and thus your organizations competitive edge.

Global supply chain management executive with a diversified background in the pharmaceutical, medical device, consumer, industrial  products and hospitality industries. Core competency in manufacturing and global strategic sourcing using McKinsey model.  Delivering constructive candor through leadership and planning.

Responsible for all chemical and packaging  suppliers for all clinical studies being conducted by Cell and Gene Therapy Division
From supplier agreements to negotiating pricing and tracking performance like OTIF-on time in full. Involved with electronic bidding thru completion of Quality Agreements from supply chain perspective.

Dr. Millhiser has been studying the operations of firms since age three when his grandfather walked him through the foundry floor of the family business, Lodge [Cast Iron] Manufacturing Co.  After a bachelors degree in Industrial Engineering, Dr. Millhiser worked in AT&T's residential long-distance arm in the 1990s.  Then, following a masters in Mathematics and a doctorate in Operations Research, he joined Baruch College’s Operations Management group in 2006 where he teaches the core operations management courses (in the BBA, MBA, EMBA, and healthcare MBA), and the “Management Science” elective in the MBA.  Dr. Millhiser’s research interests are in decision-making under risk and uncertainty, especially applied to operational decisions and in improving healthcare service delivery.  He is the 2013 recipient of the Baruch College Presidential Excellence Award for Distinguished Teaching.

Thomas Friedman has been with TSA since 2003. He currently serves as the Industry Engagement Manager for Surface Air Cargo, in the Office of Security Policy and Industry Engagement. His responsibilities include providing national policy engagement with senior level trusted operators and key associations to develop strategic Air Cargo industry partnerships. These partnerships foster relationships through frank two-way information sharing that result in a shared understanding of risk, vulnerability, and gap analysis to develop appropriate, creative security solutions that reduce measurable risk with the least impact on business. Mr Friedman serves as the principal advisor to the Assistant Administrator for the Office of Security Policy and Industry Engagement (OSPIE) for Air Cargo modal security issues and provide national aviation and surface transportation security expertise and interface to the TSA, Department of Homeland Security, Department of Transportation, White House and Congress. Prior to joining the TSA team, Mr. Friedman was employed by an International Cargo Airline. During his 19 year tenure, he served in Air Cargo operations as wells as Cargo Sales . He has worked directly with Freight Forwarders, Agents, Shippers as well as Road Feeder organizations throughout his career. Mr. Friedman’s vast knowledge of the industry has become an integral part of the TSA Air Cargo Programs office.

Brad Elrod is the Director for Global Conveyance Security at Pfizer. Brad has over 25 years of pharmaceutical industry experience, and has worked fourteen of those years with cargo security programs; ever since 9/11 events raised the concern and awareness. Brad has established cargo and supply chain security programs for Pfizer globally, working closely with partners in the United States, Europe, Latin America and Asia in support of government programs and with Law Enforcement agencies to prevent tampering and disruption of supply chains. His responsibilities include managing the CBP Customs-Trade Partnership Against Terrorism, TSA Certified Cargo Screening Program, and the new FDA Secure Supply Chain Pilot Program within Pfizer. Pfizer is a Tier 3 CTPAT Partner, and has 9 sites validated under the Certified Cargo Screening Program. Brad has served on the Board of Directors for the Transported Asset Protection Association, and is active with the Pharmaceutical Cargo Security Coalition and Rx-360. He also represents Pfizer’s Global Logistics & Supply organization as a member of their Supply Chain Security Leadership Team. Prior to work in the pharmaceutical industry, Brad served as an Infantry Officer in the US Army at various assignments. He is a graduate of the United States Military Academy at West Point and has an Executive Masters of Technology Management Degree from the University of Pennsylvania.

Priya Gopal is a Associate director, strategic planning and projects for Novartis.  She is a program manager for serialization and product tracking for Novartis, US.  She has been with Novartis for more than ten years playing various global roles in strategic planning and in program management. Priya was one of the key players in integrating of newly acquired companies Nektar and Chiron to Novartis. Priya has US lead for global wide supply chain optimization program.

Priya has her MBA in finance and is a board member of PDSA (Pharma drug security alliance)

Ravi Anupindi is the David B. Hermelin Professor of Business Administration & Professor of Operations Management. He is the Program Director for the Master of Supply Chain Management Program. He was a visiting scholar at the Graduate School of Business, Stanford University (Fall 2010) and the Indian School of Business, Hyderabad, India (Winter 2011). Prior to joining the University of Michigan in 2002, he taught at the Stern School of Business, New York University (2000-2002) and the Kellogg Graduate School of Management, Northwestern University (1993-2000).

Ravi's main research areas include supply chain management, strategic sourcing, supply chain risk management, lean operations, supply chain sustainability, value chains for economic development and global health care delivery. His current projects include decision models for commodity operations, supply chain risk management maturity framework, voluntary producer responsibility for sustainability, and health care delivery issues in TB, Malaria, and vaccines. His work has appeared in several leading journals including Management Science, Operations Research, Journal of MSOM, Marketing Science, The Lancet, and Proceedings of the National Academy of Sciences.

Ravi serves on the editorial boards of Operations Research , POMS , and Journal of M&SOM. Ravi is a member of Institute for Operations Research and Management Science (INFORMS), Council for Supply Chain Management Professionals (CSCMP), Institute for Supply Management (ISM), Supply Chain Thought Leaders (SCTL) group, Supply Chain Risk Leadership Council (SCRLC), and the Global Health Supply Chain Consortium (GHSCC). He is a member of the advisory board and executive committee for the People That Deliver Initiative for Global Health. At the University of Michigan, he serves as the Chair of the President's Advisory Committee on Labor Standards and Human Rights. He also served on the Executive Committee of the Ross School of Business.

Prashant Kulkarni works with Allergan, Inc as Director, Supply Chain Applications.  He is a senior professional with over 25 years of progressive experience in Business Transformation, Project Management, Systems Engineering, Sales & Marketing and Consulting fields. Prashant’s industry and consulting experience spans among Pharmaceuticals, Life sciences,  Chemical, Manufacturing,  and other industries including Automobile, Aerospace, Consumer Durables, Media & Entertainment, Hi-Tech and Retail. He has provided leadership on several global, full life cycle business transformation and SAP focused ERP implementation. He has also worked on large scale engineering projects and has worked on projects from various countries including USA, Canada, Mexico, India, China, Japan, Germany, Middle east and UK, to name a few.

Prashant is active in various professional forums such as PMI and ASUG. Several of his articles have been published in leading industry publications and he has been invited to speak at various industry focused seminars / conferences.

Before joining Allergan, Prashant worked as Director / Manager with Big 4 Consulting firms and Fortune 500 companies.

Prashant holds Bachelor of Engineering in Process Control and Instrumentation. He is PMI certified PMP.

Pari Sanghavi leads the Cognizant Supply Chain & Manufacturing Practice for our Life Science Clients.  Two key areas of focus within this practice are Global Serialization and End to End Supply Chain Visibility / Analytics.  Prior to joining Cognizant, as an IT Director at Bristol Myers Squibb, he had overall responsibility for designing, building and deploying multiple ERP & Supply Chain focused technologies such as SAP AII, SAP OER, SAP PI, Axway and Systech in support of the California ePedigree and Global Serialization requirements.  Over the years he has established deep industry relationships with key Serialization solution providers such as SAP, Systech, and Axway and is currently leveraging them to provide seamless systems integration services to our Clients wit

Stefan Hockenberger, author of the book ‘Track & Trace with Sap Solutions’, is a member of the board at Movilitas Consulting and leads the global Track & Trace practice with 45 dedicated SAP Track & Trace consultants around the globe. Prior to his current position with Movilitas, Stefan had been responsible for Marketing and the business unit SAP Track & Trace at Movilitas Consulting AG, the world market leader in terms of experience in the area of SAP Track & Trace with projects in 11 out of the top 15 pharmaceutical companies. From 2002 to 2009 Stefan worked as Solution Sales Executive at SAP Germany AG & Co. KG and had the overall Pre-Sales responsibility for “SAP Track & Trace” within all industries in Germany, Austria and Switzerland. Stefan holds a Master of Business Administration from the “Berufsakademie Mannheim”, University of Cooperative Education.

Dana Stiffler is a Vice President in Gartner Research. She covers supply chain talent strategies, as well as the chief supply chain officer role and individual influence and effectiveness in supply chain leadership. She launched and led the Supply Chain Strategy & Enablers team within Gartner Supply Chain Leaders for three years. Ms. Stiffler's work at AMR and then Gartner has led to direct, long-term involvement with the supply chain and sourcing leadership of global manufacturers and life sciences and CPG companies, as well as large retailers. She has been quoted in leading business publications, including the New York Times, the Financial Times and Businessweek, and numerous other business and technology publications.

Ty Bordner, Vice President of Solutions Consulting, has over 19 years of experience in the Global Trade Management software market. At Amber Road, he is responsible for customer and prospect focused solution creation.

Prior to joining Amber Road, Ty spent 10 years with JPMorgan Chase Vastera in various leadership roles, including oversight for Engineering, Solutions Consulting and Product Management. During his tenure he helped manage the company through multiple growth stages from startup, through IPO, to achieving annual revenues in excess of $80 million. Prior to joining Vastera, Ty worked for GXS (formerly GE Information Services).

Hussain has more than 20 years of experience of running supply chains, manufacturing plants, sales & marketing as well as consulting. Hussain has had great success in leading numerous initiatives including global value chain transformations, developing emerging sales models in med tech, redesigning contract manufacturing models, control tower rollouts and ERP deployments. Hussain’s previous roles have included managing vice president at Gartner and AMR Research and director at Trinity Pharma Solutions and he 

Diane is the Vice President of Manufacturing Industry Solutions at GT Nexus, combining industry expertise and technology to deliver the best possible solutions for our customers.  Diane’s career has been focused on the manufacturing sector, specifically on regulated products such as pharma and food & beverage.  Today, Diane works with best in class companies to transform supply chains through innovation and technology. Prior to GT Nexus, Diane was General Manager for an SAP partner specializing in developing products for subsidiary manufacturers in emerging markets.  Diane has an MBA from the University of Minnesota.